Publications by authors named "P Andell"
Article Synopsis
- The study examines the risk of developing cardiac arrhythmia in patients with systemic sclerosis (SSc) over time, investigating possible risk factors and the relationship between arrhythmia and mortality.
- Using Swedish national registers, researchers tracked 1,565 SSc patients and 16,009 matched controls from 2004 to 2019, finding a significantly higher incidence of arrhythmia in SSc patients compared to controls.
- The findings suggest that arrhythmia appears early in the course of SSc and is linked to increased mortality, particularly influenced by factors like male sex, older age, and pulmonary arterial hypertension.
Article Synopsis
- The study investigates how a myocardial infarction (MI) affects life expectancy by comparing patients with MI to similar individuals without it, focusing on factors like age, sex, and heart function.
- A large dataset from the SWEDEHEART registry was analyzed, revealing that younger people, women, and those with poor heart function face a greater loss of life expectancy after an MI.
- Improvements in MI treatment over the last 30 years have significantly reduced the average life expectancy loss, indicating ongoing advancements in cardiology.
Importance: There are concerns about the safety of medications for treatment of attention-deficit/hyperactivity disorder (ADHD), with mixed evidence on possible cardiovascular risk.
Objective: To assess whether short-term methylphenidate use is associated with risk of cardiovascular events.
Design, Setting, And Participants: This retrospective, population-based cohort study was based on national Swedish registry data.
Objective: Most mental disorders, when examined individually, are associated with an increased risk of cardiometabolic complications. However, these associations might be attributed to a general liability to psychopathology or confounded by unmeasured familial factors. The authors investigated the association between psychiatric conditions in young adulthood and the risk of cardiometabolic complications in middle adulthood, up to 40 years later.
View Article and Find Full Text PDF